Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multicenter Registry Study Evaluating the Feasibility of Ultrasound-guided Clipping of Suspicious Intramammary Lesions in Primary Breast Cancer Patients Receiving Neoadjuvant Therapy (Ultra3Detect)

NCT04468113 is registered in ClinicalTrials.gov with Kliniken Essen-Mitte as lead sponsor.

NCT NCT04468113
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04468113 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multicenter Registry Study Evaluating the Feasibility of Ultrasound-guided Clipping of Suspicious Intramammary Lesions in Primary Breast Cancer Patients Receiving Neoadjuvant Therapy (Ultra3Detect)
Lead sponsor
Kliniken Essen-Mitte
Phase
Observational
Overall status
Completed
Start date
May 14, 2020
Completion date
July 30, 2023
Enrollment
339 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary breast cancer